Seite auswählen

The Indian generics manufacturer Dr. Reddy’s Laboratories has decided to buy the entire stake in the Dutch generics manufacturer OctoPlus NV for EUR 27.39 million euros.

This transaction is one of the major overseas acquisitions by Dr. Reddy, after the company from Hyderabad bought the German pharmaceutical company Betapharm Arzneimittel GmbH in February 2006 for EUR 480 million.

[ilink url=““] Link zur Quelle (The Economic Times)[/ilink]